Gossamer Bio
GOSS
GOSS
129 hedge funds and large institutions have $533M invested in Gossamer Bio in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 51 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
-12
Holders Change %
-8.51%
% of All Funds
2.18%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
18
Increased
35
Reduced
51
Closed
26
Calls
$10.7M
Puts
$1.23M
Net Calls
+$9.42M
Net Calls Change
+$1.2M
Top Buyers
| 1 |
Millennium Management
New York
|
+$10.9M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$8.82M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.06M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$6.89M |
| 5 |
Citigroup
New York
|
+$6.77M |
Top Sellers
| 1 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$13.9M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.32M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$3.48M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.88M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.74M |
